Self-Assembly of Linear, Natural Antimicrobial Peptides: An Evolutionary Perspective.
Verity Baltutis,Paul D. O'Leary,Lisa L. Martin +2 more
TL;DR: Evidence of consistent self- assembly patterns across major evolutionary groups is presented, supporting the mounting data that self-assembly of antimicrobial peptides into amyloid should be considered as synergistic to the antim antibiotic peptide response.
read more
Abstract: Antimicrobial peptides are an ancient and innate system of host defence against a wide range of microbial assailants. Mechanistically, unstructured peptides undergo a secondary structure transition into amphipathic α-helices, upon contact with membrane surfaces. This leads to peptide binding and removal of the membrane components in a detergent-like manner or via self-organisation into trans-membrane pores (either barrel-stave or toroidal pore) thereby destroying the microbe. Self-assembly of antimicrobial peptides into oligomers and ultimately amyloid has been mostly examined in parallel, however recent findings link diseases, such as Alzheimer's disease as an aberrant activity of a protective neuropeptide with antimicrobial activity. These self-assembled oligomers can also interact with membranes. Here, we review those antimicrobial peptides reported to self-assemble into amyloid, where supported by structural evidence. We consider their membrane activities as antimicrobial peptides and present evidence of consistent self-assembly patterns across major evolutionary groups. Trends are apparent across these groups, supporting the mounting data that self-assembly of antimicrobial peptides into amyloid should be considered as synergistic to the antimicrobial peptide response.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Stable peptide-assembled nanozyme mimicking dual antifungal actions
Ye Yuan,Lei Chen,Kexu Song,Miaomiao Cheng,Ling Fang,Lingfei Kong,Lanlan Yu,Ruonan Wang,Zhendong Fu,Minmin Sun,Xiaogang Wang,Cong Cui,Haojue Wang,Jianxun He,Xiaonan Wang,Yuan Liu,Bing Jiang,Jing Jiang,Chenxuan Wang,Xiyun Yan,Xinzheng Zhang,Lizeng Gao +21 more
TL;DR: Researchers develop peptide-assembled nanozymes mimicking natural antimicrobial peptides and enzymes, demonstrating high thermostability and resistance to degradation, and exhibiting dual antifungal actions against Candida albicans with >90% killing efficiency within 10 minutes.
13
Exploring pathological link between antimicrobial and amyloid peptides
Yijing Tang,Yanxian Zhang,Dong Zhang,Yonglan Liu,Ruth Nussinov,Jie Zheng +5 more
TL;DR: This account aims to inspire further research and investments to enhance the understanding of the intricate molecular crosstalk between AMYs and AMPs, which holds great promise for the development of innovative therapies to combat both microbial infections and neurodegenerative disorders.
7
What can AlphaFold do for antimicrobial amyloids?
Peleg Ragonis-Bachar,Gabriel Axel,Shahar Blau,Nir Ben-Tal,Rachel Kolodny,Meytal Landau +5 more
TL;DR: The results showed that the AlphaFold2 ColabFold models favored α‐helical structures in the tested amyloids, implying that the AI‐based algorithms prefer assemblies of the monomeric state, which was frequently predicted as helical, or capture an α‐helical membrane‐active form of toxic peptides, which is triggered upon interaction with lipid membranes.
5
Biological activity of self-assembled peptide hydrogel scaffold RADA-RGD and its experimental study of BMP-2 release in vitro
Ke Huang,Quanyi Lu,Ai Guo,Bailong Tao,Hongchuan Tian,Caiping Yan,Kai Li,Dianming Jiang +7 more
TL;DR: Self-assembled peptide hydrogel scaffold RADA-RGD and its experimental study of BMP-2 release in vitro promotes cell proliferation, adhesion, and bone formation.
2
Antimicrobial Peptides and Their Assemblies
TL;DR: In this review, structure–activity relationships for AMPs and their assemblies are discussed, considering not only their self-assembly but also their interactions with their carriers for optimal delivery or their combinations with other complementary antimicrobials or moieties covalently bound to their chemical structure.
2
References
Protein Misfolding, Functional Amyloid, and Human Disease
TL;DR: The relative importance of the common main-chain and side-chain interactions in determining the propensities of proteins to aggregate is discussed and some of the evidence that the oligomeric fibril precursors are the primary origins of pathological behavior is described.
Protein folding and misfolding
TL;DR: The manner in which a newly synthesized chain of amino acids transforms itself into a perfectly folded protein depends both on the intrinsic properties of the amino-acid sequence and on multiple contributing influences from the crowded cellular milieu.
4.8K
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.
Monica Bucciantini,Elisa Giannoni,Fabrizio Chiti,Fabrizio Chiti,Fabiana Baroni,Lucia Formigli,Jesús Zurdo,Niccolò Taddei,Giampietro Ramponi,Christopher M. Dobson,Massimo Stefani +10 more
TL;DR: This finding provides added evidence that avoidance of protein aggregation is crucial for the preservation of biological function and suggests common features in the origins of this family of protein deposition diseases.
2.6K
APD3: the antimicrobial peptide database as a tool for research and education
Guangshun Wang,Xia Li,Zhe Wang +2 more
TL;DR: Newly annotated are AMPs with antibiofilm, antimalarial, anti-protist, insecticidal, spermicidal, chemotactic, wound healing, antioxidant and protease inhibiting properties and various database applications in research and education are summarized.
1.9K
The expanding scope of antimicrobial peptide structures and their modes of action.
TL;DR: Several intact proteins or protein fragments are now being shown to have inherent antimicrobial activity, suggesting a better understanding of the structure-activity relationships of AMPs is required to facilitate the rational design of novel antimicrobial agents.
1.5K